The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
The target is the budding-yeast mitotic cyclin Clb2, not an unrelated similarly named protein. The supplied UniProt record identifies P24869, gene CLB2, ordered locus YPR119W, in Saccharomyces cerevisiae S288c, and annotates cyclin/cyclin-like domains belonging to the cyclin A/B subfamily. This identity is fully consistent with the literature, which describes Clb2 as the principal B-type G2/M cyclin and regulatory partner of Cdc28, the sole major cell-cycle Cdk1 in budding yeast. The retrieved papers did not independently remap P24869 to YPR119W, so those accession, locus, strain, and domain identifiers should be regarded as verified against the supplied UniProt context rather than newly established by the literature search. No evidence concerning a different “CLB2” gene was used.
Clb2 is not itself an enzyme. Its primary function is to bind, activate, spatially direct, and confer substrate preference on the serine/threonine kinase Cdc28/Cdk1. The Clb2–Cdc28 complex supplies the dominant high-CDK activity of late G2 and mitosis, coordinating mitotic transcription, bipolar-spindle assembly, changes in bud morphogenesis, suppression of replication-origin relicensing, and inhibition of premature mitotic exit. One literature synthesis estimates that Clb2 accounts for approximately 85% of Cdc28 promitotic activity. Clb2 destruction at anaphase/mitotic exit then helps make cell-cycle progression irreversible. (freire2012mathematicalmodellingof pages 24-28, ehret2021dynamicsandpartitioning pages 19-22)
The evidence map below distinguishes direct experiments from database-level identity fields and less completely documented localization claims.
| Annotation aspect | Mechanistic conclusion | Strongest experimental evidence | Key molecules/sites | Evidence strength / limitations |
|---|---|---|---|---|
| Identity and family | Target is Clb2, the G2/mitotic B-type cyclin of Saccharomyces cerevisiae S288c: CLB2/YPR119W, UniProt P24869; cyclin A/B-family cyclin-like domains agree with its mitotic cyclin function. | Literature consistently identifies yeast Clb2 as the principal B-type mitotic cyclin; however, accession, locus, strain, and InterPro-domain mappings were supplied as UniProt metadata rather than independently established by the retrieved papers. (vigano2011yeastcellsize pages 78-82, ehret2021dynamicsandpartitioning pages 19-22) | P24869; YPR119W; cyclin A/B-like and cyclin C-terminal domains | High identity coherence, but database identifiers/domains rely on supplied metadata. No literature concerning a different CLB2 was used. |
| Primary molecular function | Clb2 is not an enzyme. It is a regulatory cyclin that binds and activates the serine/threonine kinase Cdc28/Cdk1 and helps determine the timing, localization, and substrate selection of high mitotic CDK activity. | Genetic and biochemical literature places Clb2–Cdc28 at mitotic entry; one synthesis attributes approximately 85% of Cdc28 promitotic activity to Clb2. (freire2012mathematicalmodellingof pages 24-28, ehret2021dynamicsandpartitioning pages 19-22) | Clb2; Cdc28/Cdk1; CDK substrates generally enriched for S/T-P motifs | Strong, although the 85% estimate is a secondary citation rather than a new measurement. |
| Mitotic transcriptional feedback | Clb2–Cdc28 reinforces the mitotic transcriptional wave by phosphorylating Ndd1 and Fkh2: Ndd1 recruitment to the CLB2 promoter rises, and the Fkh2–Ndd1 interaction is strengthened. Clb2–Cdc28 also inhibits SBF, helping shut down the G1 program. | Biochemical and promoter-regulation studies summarized in an authoritative cyclin-specificity review support direct phosphorylation and positive autoregulation; the CLB2 cluster contains roughly 35 genes. (bloom2007multiplelevelsof pages 3-4, ehret2021dynamicsandpartitioning pages 19-22, vigano2011yeastcellsize pages 78-82) | Mcm1–Fkh2–Ndd1; SBF; CLB2 promoter | Strong mechanistic support; exact phosphosites were not recovered in the examined excerpts. |
| Spindle assembly | Clb2–Cdc28 promotes bipolar-spindle formation by phosphorylating kinesin-5 motors, especially Kip1; the effect is on motor function rather than simply abundance or spindle localization. | Clb2–Cdc28 phosphorylated Kip1 and Cin8 in vitro. LC–MS/MS found 8 Kip1 and 4 Cin8 phosphosites. Nonphosphorylatable Kip1 alleles impaired spindle-pole-body separation without reducing protein abundance or localization. (chee2010bcyclincdksregulatemitotic pages 1-2, chee2010bcyclincdksregulatemitotic pages 10-11, chee2010bcyclincdksregulatemitotic pages 7-8) | Kip1 S388, S1037, T1040; Cin8 S972; additional Kip1 sites S213, S802, S952, T1068, T1088 | Strong direct evidence from biochemistry, phosphoproteomics, and genetics. Some detected sites may not all be direct or functionally important. |
| Replication licensing control | During mitosis, Clb2–Cdk1–Cks1 binds phosphorylated Cdc6, stabilizing it while preventing its licensing activity. Mitotic exit releases this complex so Cdc6 can load Mcm2–7 and license replication origins. | Purified-protein phosphatase assays, motif mutants, and interaction analyses support sequential regulation by PP2A-Cdc55, Cdc14, and Sic1. (philip2022cdc6issequentially pages 1-2, philip2022cdc6issequentially pages 13-15, philip2022cdc6issequentially pages 9-10) | Cdc6 T7/T23; degrons T39–S43 and T368–S372; docking motifs 30-RxL-32, 47-LQF-49, and 126-FQSLP-130; Cks1; Mcm2–7 | Strong and relatively recent direct evidence (2022). Clb5 primes some Cdc6 phosphorylation, so not every step is Clb2-specific. |
| Morphogenesis-checkpoint input | Swe1 preferentially recognizes the Clb2-containing kinase, promotes inhibitory phosphorylation of Cdc28 Y19, and delays mitotic progression when morphogenesis is defective. Clb2’s cyclin surface supplies this partner specificity. | Reciprocal Clb2/Clb5 mutagenesis showed that Clb2 N260 and K270 are needed for stable Swe1 association, Swe1 phosphorylation by Clb2–Cdc28, and efficient Swe1 regulation; corresponding Clb5 substitutions conferred Swe1 sensitivity. (hu2008identificationofclb2 pages 1-2) | Clb2 N260/K270; cyclin hydrophobic-patch region; Swe1; Cdc28 Y19; opposing phosphatase Mih1 | Strong direct structure–function evidence. Swe1 can also act as a binding inhibitor, but Y19 phosphorylation is the canonical inhibitory output. |
| Cell-shape and bud-growth program | Rising Clb1/2–Cdc28 activity switches growth from polarized apical extension toward isotropic bud growth by depolarizing cortical actin and the secretory apparatus; subsequent CDK inactivation permits actin redistribution to the bud neck for cytokinesis. | Acute manipulation of Cdc28–cyclin activity altered cortical actin organization even under conditions used to distinguish direct cell-cycle control from new protein synthesis. (measday1998rolesofthe pages 33-37) | Clb1/Clb2–Cdc28; cortical actin; secretory apparatus; bud neck | Strong physiological evidence, but the retrieved excerpt treats Clb1 and Clb2 together and does not identify a direct Clb2-specific actin substrate. |
| Proteolysis and mitotic exit | Clb2 destruction is a causal component of CDK downregulation: APC/C–Cdc20 initiates mitotic cyclin proteolysis around metaphase/anaphase, while APC/C–Cdh1 completes Clb2 removal in late mitosis/G1. Cdc14-mediated Cdh1 activation and Sic1 accumulation consolidate the low-CDK exit state. | Genetic, biochemical, and systems analyses converge on sequential APC/C activation; persistent or overexpressed Clb2 can block mitotic exit. (freire2012mathematicalmodellingof pages 24-28, bloom2007multiplelevelsof pages 3-4, freire2012mathematicalmodellingof pages 32-37) | APC/C–Cdc20; APC/C–Cdh1; Clb2 degrons; Cdc14; Sic1 | Strong pathway-level evidence. Exact Clb2 half-life and destruction kinetics were not available in the retrieved passages. |
| Localization | Clb2 function is spatially compartmentalized across the nucleus/mitotic apparatus and mother–bud neck, consistent with nuclear transcription/replication targets, spindle regulation, and morphogenesis. CLB2 mRNA has also been reported as predominantly bud-localized while Clb2 protein is not similarly restricted. | Retrieved text directly supports spatially distinct outputs and the mRNA–protein localization contrast, but did not provide the strongest primary microscopy study documenting Clb2 at each compartment. (ehret2021dynamicsandpartitioning pages 19-22, bloom2007multiplelevelsof pages 3-4) | Nucleus; spindle/SPBs; mother–bud neck; bud-localized CLB2 mRNA | Moderate/limited. Compartment-specific localization should be treated as supported by prior microscopy literature but less completely documented in the retrieved full-text evidence than the biochemical functions. |
Table: Compact evidence map for budding-yeast Clb2/P24869, separating experimentally established mechanisms from database-supplied identity fields and less completely supported localization claims.
Clb2’s cyclin fold binds Cdc28 and reorganizes the kinase into an active complex. Catalysis—transfer of phosphate from ATP to protein serine/threonine residues—is performed by Cdc28, not by Clb2. Cyclin identity matters because it controls when the kinase is active, where it acts, and which substrates are efficiently recruited. Clb2–Cdc28 generally recognizes proline-directed CDK sites, minimally S/T-P, with basic residues in an extended consensus increasing efficiency; substrate docking, Cks1-dependent phospho-adaptor interactions, and compartmentalization further refine specificity. Clb2 is therefore best annotated as a non-catalytic mitotic CDK regulatory subunit and substrate-targeting factor, rather than as an enzyme with a small-molecule substrate. (freire2012mathematicalmodellingof pages 24-28, zheng2024probingcellcycle pages 26-30)
A particularly clear demonstration of cyclin-dependent specificity involves the morphogenesis-checkpoint kinase Swe1. Mutational exchange between Clb2 and the S-phase cyclin Clb5 identified Clb2 N260 and K270, adjacent to the conserved cyclin hydrophobic-patch surface, as necessary for stable Swe1 association, Clb2–Cdc28-mediated phosphorylation of Swe1, and efficient Swe1 inhibition of Cdc28. Reciprocal substitutions made Clb5–Cdc28 Swe1-sensitive. Swe1 preferentially inhibits Clb2–Cdc28 by phosphorylating Cdc28 Y19, whereas Mih1 reverses this modification. Thus, Clb2’s surface helps couple defective bud morphogenesis to delayed mitosis. (freire2012mathematicalmodellingof pages 24-28, hu2008identificationofclb2 pages 1-2)
Kip1 and Cin8—spindle assembly. Purified Clb2–Cdc28 phosphorylates both kinesin-5 motors in vitro. LC–MS/MS identified eight high-confidence Kip1 phosphosites and four Cin8 sites. Functionally important Kip1 sites include S388, S1037, and T1040; phosphorylation of S1037 and Cin8 S972 decreased when Clb/Cdc28 was inhibited and increased with Clb2 overexpression. Nonphosphorylatable Kip1 mutants delayed or prevented spindle-pole-body separation without reducing Kip1 abundance or localization, showing that Clb2–Cdc28 regulates motor function rather than merely stabilizing or targeting the motor. Cin8 S972 alone had no detectable phenotype in the tested sensitized background, illustrating that a detected phosphosite is not necessarily functionally decisive. (chee2010bcyclincdksregulatemitotic pages 1-2, chee2010bcyclincdksregulatemitotic pages 10-11, chee2010bcyclincdksregulatemitotic pages 7-8)
Ndd1 and Fkh2—mitotic transcription. Clb2–Cdc28 phosphorylates the coactivator Ndd1 to promote its recruitment to the Mcm1–Fkh2 complex at the CLB2 promoter and phosphorylates Fkh2 to strengthen the Fkh2–Ndd1 interaction. This produces positive feedback in which rising Clb2 activity accelerates expression of CLB2 and an approximately 35-gene CLB2 cluster of mitotic regulators. Clb2–Cdc28 also inhibits SBF, helping terminate the earlier G1 transcriptional program. (bloom2007multiplelevelsof pages 3-4, ehret2021dynamicsandpartitioning pages 19-22, vigano2011yeastcellsize pages 78-82)
Cdc6—replication licensing. Cdc6 has eight S/T-P CDK sites. During mitosis, Clb2–Cdk1–Cks1 binds phosphorylated Cdc6 through phosphosite- and motif-dependent interactions, including Cdc6 T7/T23, 47-LQF-49, and 126-FQSLP-130. This complex stabilizes Cdc6 by shielding phosphodegrons while preventing Cdc6 from licensing origins. At exit, PP2A-Cdc55 removes N-terminal phosphates, Cdc14 removes a C-terminal phosphodegron, and Sic1 inhibits/releases Clb2–Cdk1–Cks1, permitting Mcm2–7 loading. This is strong evidence that Clb2 prevents DNA rereplication not simply by destroying licensing factors, but also by holding Cdc6 in an inactive mitotic complex. (philip2022cdc6issequentially pages 1-2, philip2022cdc6issequentially pages 13-15, philip2022cdc6issequentially pages 9-10)
CLB2 expression rises in late G2, and Clb2–Cdc28 drives entry into mitosis. Genetic evidence shows that loss of CLB2 delays mitosis, whereas combined loss of CLB1 and CLB2 causes G2 arrest with a formed spindle; conversely, cells lacking CLB1, CLB3, and CLB4 can remain viable, indicating that Clb2 alone can provide much of the essential mitotic cyclin function. Excess or nondegradable Clb2 can arrest cells in mitosis. (freire2012mathematicalmodellingof pages 24-28, measday1998rolesofthe pages 33-37)
Its spindle role includes direct activation of kinesin-5-dependent spindle-pole separation, as described above, and coordination of a broader mitotic transcriptional program involving spindle-pole-body duplication and spindle assembly. The strongest mechanistic attribution is therefore not merely “cell-cycle regulation,” but generation of high mitotic Cdk1 activity that initiates and maintains the bipolar-spindle and M-phase state. (ehret2021dynamicsandpartitioning pages 19-22, chee2010bcyclincdksregulatemitotic pages 1-2)
Clb1/2–Cdc28 activity converts polarized apical bud growth into isotropic growth by depolarizing cortical actin and the secretory apparatus. Later loss of mitotic CDK activity permits actin redistribution to the mother–bud neck for cytokinesis. These physiological experiments establish a role for mitotic cyclin–Cdc28 activity in morphogenesis, although the retrieved evidence treats Clb1 and Clb2 jointly and does not establish a unique direct actin substrate of Clb2–Cdc28. (measday1998rolesofthe pages 33-37)
The Swe1–Mih1 checkpoint overlays this program. Defective bud formation activates Swe1-dependent Cdc28 Y19 inhibition, delaying Clb2-driven mitosis until morphogenesis is adequate. The Clb2 N260/K270 interaction surface explains why this checkpoint preferentially targets mitotic rather than S-phase cyclin complexes. (hu2008identificationofclb2 pages 1-2)
Clb2 both promotes mitosis and delays exit while its kinase activity remains high. APC/C–Cdc20 begins destruction of mitotic cyclins around the metaphase–anaphase transition. Subsequent Cdc14-dependent dephosphorylation activates Cdh1, and APC/C–Cdh1 completes Clb2 degradation and maintains low cyclin abundance through G1. Sic1 supplies a parallel stoichiometric inhibition mechanism. These mutually antagonistic modules—high Clb2–Cdk1 versus APC/C–Cdh1, Cdc14, and Sic1—create switch-like mitotic entry and exit. (bloom2007multiplelevelsof pages 3-4, freire2012mathematicalmodellingof pages 24-28, freire2012mathematicalmodellingof pages 32-37)
Clb2 acts predominantly in intracellular mitotic compartments. Nuclear functions are strongly implied by its direct control of Ndd1/Fkh2 transcription and Cdc6-dependent origin licensing; spindle and spindle-pole functions are demonstrated through Kip1/Cin8 phosphorylation; morphogenetic outputs occur at the cortex and mother–bud neck. Earlier microscopy literature reports compartmentalization of Clb2 between the nucleus, mitotic apparatus, cytoplasm, and bud neck, but the strongest primary localization articles were not available in full text in this retrieval. Accordingly, exact claims such as a stage-resolved percentage at each compartment should not be made from the present evidence.
An intriguing spatial observation is that CLB2 mRNA is predominantly bud-localized whereas Clb2 protein is not similarly restricted. This has motivated models in which transcript positioning helps couple daughter-cell growth or biosynthetic capacity to mitotic progression, but it is not yet equivalent to a demonstrated local catalytic requirement. (ehret2021dynamicsandpartitioning pages 19-22)
Direct 2023–2024 papers devoted specifically to S. cerevisiae Clb2 were sparse. Recent work instead refines the framework in which Clb2 operates:
The most important recent direct mechanistic advance within the retrieved literature remains the 2022 Cdc6 study, which resolved how PP2A-Cdc55, Cdc14, Sic1, Cks1, and Clb2 sequentially control licensing at mitotic exit. (philip2022cdc6issequentially pages 1-2, philip2022cdc6issequentially pages 13-15)
Clb2 is primarily a research-system component, not an industrial enzyme or clinical target. Its established applications include synchronized yeast cell-cycle experiments; inducible mitotic arrest; analysis of APC/C-mediated proteolysis; kinase-substrate and phosphosite validation; quantitative models of cell-cycle bistability and oscillation; and fluorescent or transcript-localization reporters. Because the Cdk1–cyclin-B/APC/C architecture is conserved, Clb2 studies have also supplied mechanistic principles relevant to chromosome instability and antiproliferative drug research, although yeast Clb2 itself is not a human therapeutic target.
The expert consensus supported by the evidence is that Clb2 should be annotated narrowly as the dominant budding-yeast G2/M cyclin that activates and targets Cdc28/Cdk1. Its best-established precise outputs are positive feedback on mitotic transcription, phosphorylation-dependent kinesin-5 control, inhibition of origin licensing through Cdc6, morphogenesis-checkpoint coupling through Swe1, and maintenance of the mitotic state until APC/C-dependent destruction. Broad phenotypes—cell shape, chromosome segregation, bud growth, and cytokinesis—are downstream consequences of this core kinase-regulatory role rather than evidence that Clb2 is itself a structural protein or catalytic enzyme.
References
(freire2012mathematicalmodellingof pages 24-28): P Freire and P Freire. Mathematical modelling of mitotic exit control in budding yeast cell cycle. Unknown journal, 2012.
(ehret2021dynamicsandpartitioning pages 19-22): Severin Ehret. Dynamics and partitioning of single clb2 mrna and its role in cell cycle progression. ArXiv, Nov 2021. URL: https://doi.org/10.18452/23613, doi:10.18452/23613. This article has 0 citations.
(vigano2011yeastcellsize pages 78-82): M Vigano. Yeast cell size control: an interplay among ribosome biogenesis, protein synthesis and mapk routes. Unknown journal, 2011.
(bloom2007multiplelevelsof pages 3-4): Joanna Bloom and Frederick R. Cross. Multiple levels of cyclin specificity in cell-cycle control. Nature Reviews Molecular Cell Biology, 8:149-160, Feb 2007. URL: https://doi.org/10.1038/nrm2105, doi:10.1038/nrm2105. This article has 743 citations and is from a domain leading peer-reviewed journal.
(chee2010bcyclincdksregulatemitotic pages 1-2): Mark K. Chee and Steven B. Haase. B-cyclin/cdks regulate mitotic spindle assembly by phosphorylating kinesins-5 in budding yeast. PLoS Genetics, 6:e1000935, May 2010. URL: https://doi.org/10.1371/journal.pgen.1000935, doi:10.1371/journal.pgen.1000935. This article has 78 citations and is from a domain leading peer-reviewed journal.
(chee2010bcyclincdksregulatemitotic pages 10-11): Mark K. Chee and Steven B. Haase. B-cyclin/cdks regulate mitotic spindle assembly by phosphorylating kinesins-5 in budding yeast. PLoS Genetics, 6:e1000935, May 2010. URL: https://doi.org/10.1371/journal.pgen.1000935, doi:10.1371/journal.pgen.1000935. This article has 78 citations and is from a domain leading peer-reviewed journal.
(chee2010bcyclincdksregulatemitotic pages 7-8): Mark K. Chee and Steven B. Haase. B-cyclin/cdks regulate mitotic spindle assembly by phosphorylating kinesins-5 in budding yeast. PLoS Genetics, 6:e1000935, May 2010. URL: https://doi.org/10.1371/journal.pgen.1000935, doi:10.1371/journal.pgen.1000935. This article has 78 citations and is from a domain leading peer-reviewed journal.
(philip2022cdc6issequentially pages 1-2): Jasmin Philip, Mihkel Örd, Andriele Silva, Shaneen Singh, John FX Diffley, Dirk Remus, Mart Loog, and Amy E Ikui. Cdc6 is sequentially regulated by pp2a-cdc55, cdc14, and sic1 for origin licensing in s. cerevisiae. eLife, Feb 2022. URL: https://doi.org/10.7554/elife.74437, doi:10.7554/elife.74437. This article has 10 citations and is from a domain leading peer-reviewed journal.
(philip2022cdc6issequentially pages 13-15): Jasmin Philip, Mihkel Örd, Andriele Silva, Shaneen Singh, John FX Diffley, Dirk Remus, Mart Loog, and Amy E Ikui. Cdc6 is sequentially regulated by pp2a-cdc55, cdc14, and sic1 for origin licensing in s. cerevisiae. eLife, Feb 2022. URL: https://doi.org/10.7554/elife.74437, doi:10.7554/elife.74437. This article has 10 citations and is from a domain leading peer-reviewed journal.
(philip2022cdc6issequentially pages 9-10): Jasmin Philip, Mihkel Örd, Andriele Silva, Shaneen Singh, John FX Diffley, Dirk Remus, Mart Loog, and Amy E Ikui. Cdc6 is sequentially regulated by pp2a-cdc55, cdc14, and sic1 for origin licensing in s. cerevisiae. eLife, Feb 2022. URL: https://doi.org/10.7554/elife.74437, doi:10.7554/elife.74437. This article has 10 citations and is from a domain leading peer-reviewed journal.
(hu2008identificationofclb2 pages 1-2): Fangfang Hu, Yan Gan, and Oscar M Aparicio. Identification of clb2 residues required for swe1 regulation of clb2-cdc28 in saccharomyces cerevisiae. Genetics, 179:863-874, Jun 2008. URL: https://doi.org/10.1534/genetics.108.086611, doi:10.1534/genetics.108.086611. This article has 30 citations and is from a domain leading peer-reviewed journal.
(measday1998rolesofthe pages 33-37): VR Measday. Roles of the pho85 cyclin-dependent kinase in budding yeast. Unknown journal, 1998.
(freire2012mathematicalmodellingof pages 32-37): P Freire and P Freire. Mathematical modelling of mitotic exit control in budding yeast cell cycle. Unknown journal, 2012.
(zheng2024probingcellcycle pages 26-30): H Zheng. Probing cell cycle commitment and global transcription regulation at the single-molecule level in budding yeast. Unknown journal, 2024.
(ravi2024modelingthestart pages 30-31): Janani Ravi, Kewalin Samart, and Jason Zwolak. Modeling the start transition in the budding yeast cell cycle. Aug 2024. URL: https://doi.org/10.1371/journal.pcbi.1012048, doi:10.1371/journal.pcbi.1012048. This article has 1 citations and is from a highest quality peer-reviewed journal.